B-type natriuretic peptide in reversible myocardial ischaemia

Journal of Clinical Pathology

Volumn 59, Issue 11, 2006, Pages 1216-1217

  Chatha, K ^a   Alsoud, M ^a   Griffiths, M J ^a   Elfatih, A ^a   Abozguia, K ^a   Horton, R C ^a   Dunmore, S J ^b   Gama, R ^a  

^a NEW CROSS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXERCISE ELECTROCARDIOGRAPHY; EXERCISE TOLERANCE; FEMALE; HEART INFARCTION; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; ELECTROCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN;

EID: 33751242017     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.034702     Document Type: Article

References (14)

1. Struthers AD, Davies J. B-type natriuretic peptide: a simple new test to identify coronary heart disease. QJM 2005;98:765-9.
2. Omland T. Clinical and laboratory diagnostics of cardiovascular disease: focus on natriuretic peptides and cardiac ischemia. Scand J Clin Lab Invest Suppl 2005;240:18-24.
3. Weber T, Auer J, Eber B. The diagnostic and prognostic value of brain natriuretic peptide and aminoterminal (nt)-pro brain natriuretic peptide. Curr Pharm Des 2005;11:511-25.
4. Yeo KT, Lee HK, Wong KC, et al. Can exercise-induced changes in B-type natriuretic peptides be used to detect cardiac ischemia? J Cardiac Fail 2005;11:S59-64.
5. Marumoto K, Hamada M, Aburaya M, et al. Augmented secretion of atrial and brain natriuretic peptides during dynamic exercise in patients with old myocardial infarction. Jpn Circ J 1995;59:715-24.
6. Marumoto K, Hamada M, Hiwada K. Increased secretion of atrial and brain natuiretic peptides during acute myocardial ischaemia induced by dynamic exercise in patient with angina pectoris. Clin Sci 1995;88:551-6.
7. Nicholson S, Richards M, Espiner E, et al. Atrial and brain natriuretic peptide response to exercise in patients with ischaemic heart disease. Clin Exp Pharmacol Physiol 1993;20:535-40.
8. Foote RS, Pearlman JD, Siegel AH, et al. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 2004;44:1980-7.
9. Sabatine MS, Morrow DA, de Lemos JA, et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 2004;16:1988-95.
10. WinWin HK, Chang SM, Raizner M, et al. Percent change in B-type natriuretic peptide levels during treadmill exercise as a screening test for exercise-induced myocardial ischemia. Am Heart J 2005; 150:695-700.
11. Asada J, Tsuji H, Iwasaka T, et al. Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemia. Am J Cardiol 2004;93:702-4.
12. Weber M, Dill T, Arnold R, et al. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J 2004;148:612-20.
13. Hill J, Timmis A. Exercise tolerance testing. BMJ 2002;424:1084-7.
14. Loke I, Squire IB, Davies JE, et al. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate. Eur J Heart Fail 2003;5:599-606.